Clinical Trial Update: Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic arterial infusion oxaliplatin with systemic FOLFIRI and bevacizumab for initially inoperable liver-only colorectal liver metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Liver Metastasis
• Liver Metastasis

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Oxaliplatin (hepatic arterial infusion) (oxaliplatin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Liver Metastasis Colon Cancer | Phase 2 | Status: UNKNOWN